Pirfenidone Therapy for Familial Pulmonary Fibrosis: A Real-Life Study

ConclusionDifferent rate of progression was observed in patients with IPF and FPF on therapy with pirfenidone; our findings may not be due to lack of effectiveness of therapy, but to the different natural history and evolution of these two conditions. Pirfenidone was well tolerated by FPF and IPF patients. Specific unbiased randomized clinical trials on larger populations to validate our preliminary exploratory results are needed.
Source: Lung - Category: Respiratory Medicine Source Type: research